Smilow Cancer Center at Yale-New Haven ( Site 3253) — New Haven, Connecticut

Public research footprint of Smilow Cancer Center at Yale-New Haven ( Site 3253), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer (NSCLC) · Metastatic Hormone-Sensitive Prostate Cancer · Melanoma · Head and Neck Squamous Cell Carcinoma

Recently updated registry entries

NCT07513376 — A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated… (Recruiting)
NCT05382559 — A Study of ASP3082 in Adults With Advanced Solid Tumors (Recruiting)
NCT03740165 — Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Smilow Cancer Center at Yale-New Haven ( Site 3253)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.